Spots Global Cancer Trial Database for 5fu
Every month we try and update this database with for 5fu cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer | NCT00463840 | Pancreatic Canc... | Oxaliplatin 5FU Radiation Surgery FOLFOX 6 | 18 Years - | NYU Langone Health | |
| FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer | NCT01688336 | Pancreatic Canc... | FOLFIRINOX | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait | NCT05000697 | Rectal Cancer Consolidation | Oxaliplatin 5FU | 18 Years - | Hospital Alemão Oswaldo Cruz | |
| The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer | NCT05628038 | Recurrent Recta... | PD-1 antibody Capecitabine 5FU folinic acid Oxaliplatin Irinotecan Raltitrexed Radiation | 18 Years - 75 Years | Fudan University | |
| Curcumin in Combination With 5FU for Colon Cancer | NCT02724202 | Metastatic Colo... | Curcumin 5-flurorouracil | 18 Years - | Baylor Research Institute | |
| A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer | NCT01926769 | Previously Trea... | Metformin | 18 Years - | Gachon University Gil Medical Center | |
| Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer | NCT04447092 | Pancreatic Canc... Chemotherapy Ef... | Gemcitabine Nab-paclitaxel Pembrolizumab Oxaliplatin Leucovorin Irinotecan 5FU | 18 Years - | Seoul National University Hospital | |
| Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation | NCT01151761 | Cholangiocarcin... Hepatobiliary N... Liver Cancer Bile Duct Cance... Cancer of Gallb... | Stereotactic Bo... Gemcitabine Cisplatin Carboplatin Capecitabine 5FU Liver transplan... | 18 Years - | Stanford University | |
| Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea | NCT00255229 | Metastatic Colo... | Glutamine Placebo | 18 Years - | AHS Cancer Control Alberta | |
| Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer | NCT04447092 | Pancreatic Canc... Chemotherapy Ef... | Gemcitabine Nab-paclitaxel Pembrolizumab Oxaliplatin Leucovorin Irinotecan 5FU | 18 Years - | Seoul National University Hospital | |
| Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer | NCT00463840 | Pancreatic Canc... | Oxaliplatin 5FU Radiation Surgery FOLFOX 6 | 18 Years - | NYU Langone Health | |
| Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation | NCT01151761 | Cholangiocarcin... Hepatobiliary N... Liver Cancer Bile Duct Cance... Cancer of Gallb... | Stereotactic Bo... Gemcitabine Cisplatin Carboplatin Capecitabine 5FU Liver transplan... | 18 Years - | Stanford University | |
| A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck | NCT00756444 | Squamous Cell C... | Panitumumab Cisplatin 5FU | 18 Years - | Amgen | |
| Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea | NCT00255229 | Metastatic Colo... | Glutamine Placebo | 18 Years - | AHS Cancer Control Alberta | |
| A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer | NCT02013453 | Cancer of Head ... | Omeprazole Carboplatin 5FU Paclitaxel Pemetrexed | 18 Years - | University of Michigan Rogel Cancer Center | |
| ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer | NCT02688712 | Rectal Adenocar... | LY2157299 Capecitabine Fluorouracil Tumor specific ... | 18 Years - | Providence Health & Services | |
| Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus | NCT01581840 | Epidermoid Carc... Anus | radiochemothera... Panitumumab | 18 Years - | Federation Francophone de Cancerologie Digestive | |
| The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer | NCT05628038 | Recurrent Recta... | PD-1 antibody Capecitabine 5FU folinic acid Oxaliplatin Irinotecan Raltitrexed Radiation | 18 Years - 75 Years | Fudan University | |
| A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer | NCT01926769 | Previously Trea... | Metformin | 18 Years - | Gachon University Gil Medical Center | |
| Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancer | NCT05751265 | Gastric Cancer | Tislelizumab 5Fu Paclitaxel inje... | 18 Years - 75 Years | Fujian Cancer Hospital | |
| Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma | NCT00682786 | Rectal Carcinom... | 5FU Radiation Surgery of rese... Irinotecan | 18 Years - | Washington University School of Medicine | |
| Panitumumab, Paclitaxel, Carboplatin and 5FU in the Treatment of Potentially Resectable Gastroesophageal Adenocarcinoma | NCT01182610 | Gastroesophagea... Adenocarcinoma ... Adenocarcinomas... Adenocarcinoma ... | Panitumumab Paclitaxel Carboplatin 5FU | 18 Years - | Accelerated Community Oncology Research Network | |
| Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma | NCT00682786 | Rectal Carcinom... | 5FU Radiation Surgery of rese... Irinotecan | 18 Years - | Washington University School of Medicine | |
| Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver | NCT03366155 | Colorectal Canc... Liver Metastase... Colorectal Aden... Colorectal Canc... Colorectal Carc... | Codman 3000 con... Panitumumab FUDR-Dex Oxaliplatin 5FU Irinotecan HAIP installati... cetuximab Medtronic Synch... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer | NCT05628038 | Recurrent Recta... | PD-1 antibody Capecitabine 5FU folinic acid Oxaliplatin Irinotecan Raltitrexed Radiation | 18 Years - 75 Years | Fudan University | |
| Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus | NCT01581840 | Epidermoid Carc... Anus | radiochemothera... Panitumumab | 18 Years - | Federation Francophone de Cancerologie Digestive | |
| A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer | NCT01926769 | Previously Trea... | Metformin | 18 Years - | Gachon University Gil Medical Center | |
| FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer | NCT01688336 | Pancreatic Canc... | FOLFIRINOX | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer | NCT03801876 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Thoracic Esopha... | Carboplatin Esophagectomy Intensity-Modul... Paclitaxel Proton Beam Rad... Quality-of-Life... Questionnaire A... FOLFOX regimen CAPOX regimen Docetaxel 5FU | 18 Years - | NRG Oncology | |
| A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck | NCT00756444 | Squamous Cell C... | Panitumumab Cisplatin 5FU | 18 Years - | Amgen | |
| Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer | NCT01926197 | Pancreatic Canc... | Oxaliplatin Irinotecan Leucovorin 5FU Stereotactic Bo... | 18 Years - | Stanford University | |
| A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer | NCT01671488 | Anal Cancer | Treatment 5FU Mitomycin IMRT | 18 Years - | Brown University | |
| FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer | NCT05018182 | High-risk Local... Neoadjuvant Che... FOLFOXIRI Regim... | Oxaliplatin Irinotecan Folinic Acid 5FU Capecitabine | 18 Years - 70 Years | West China Hospital | |
| Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver | NCT03366155 | Colorectal Canc... Liver Metastase... Colorectal Aden... Colorectal Canc... Colorectal Carc... | Codman 3000 con... Panitumumab FUDR-Dex Oxaliplatin 5FU Irinotecan HAIP installati... cetuximab Medtronic Synch... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus | NCT01581840 | Epidermoid Carc... Anus | radiochemothera... Panitumumab | 18 Years - | Federation Francophone de Cancerologie Digestive | |
| Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait | NCT05000697 | Rectal Cancer Consolidation | Oxaliplatin 5FU | 18 Years - | Hospital Alemão Oswaldo Cruz |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
